Welcome to our dedicated page for Hanover Insuranc SEC filings (Ticker: THG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Hanover Insurance Group’s filings do more than report numbers—they reveal how an insurer balances catastrophe exposure, underwriting margins, and a $10-billion fixed-income portfolio. If you have ever searched for “The Hanover Insurance Group insider trading Form 4 transactions” or wondered where segment combined-ratio details hide, you know these disclosures run deep.
Stock Titan’s AI reads every 10-K, 10-Q, 8-K, and proxy the moment it posts to EDGAR. Need the The Hanover Insurance Group quarterly earnings report 10-Q filing? We highlight loss-ratio shifts and reserve releases in seconds. Curious about The Hanover Insurance Group executive stock transactions Form 4? Real-time alerts surface buys and sells before the market digests them. Our AI-powered summaries translate actuarial language into plain English, delivering “The Hanover Insurance Group SEC filings explained simply.”
Whether you’re tracking dividend capacity in the annual report—The Hanover Insurance Group annual report 10-K simplified—or scanning an 8-K for hurricane-related loss estimates—The Hanover Insurance Group 8-K material events explained—the platform connects each filing to practical actions. Compare quarter-over-quarter catastrophe costs, monitor reserve adequacy, or review The Hanover Insurance Group proxy statement executive compensation without wading through hundreds of pages. From Form 4 insider transactions real-time to earnings report filing analysis, Stock Titan turns complex insurance disclosures into clear, decision-ready insights.
John C. Roche, President and CEO and Director of The Hanover Insurance Group, Inc. (THG), reported a grant of 132.183 restricted stock units (RSUs) on 09/26/2025 under the company's 2022 Long-Term Incentive Plan. The filing shows the RSUs were issued at $0 in connection with accrued dividend equivalent rights tied to previously granted RSUs, and those units vest on the third anniversary of the original grant date. After this transaction the reporting person beneficially owns 124,686.639 shares. The report notes 14,454 shares held by the reporting person’s spouse are not included in that total.
Form 4 disclosure: Executive Vice President Jeffrey M. Farber of The Hanover Insurance Group (THG) reported an acquisition on 09/26/2025 of 48.815 shares of common stock in the form of restricted stock units (RSUs) at a $0 price. After the grant, he beneficially owns 45,991.495 shares. The filing states these RSUs were issued under the company’s 2022 Long-Term Incentive Plan as dividend equivalent accruals tied to earlier RSU awards and will vest on the third anniversary of the original grants.
This is an insider compensation-related grant rather than an open-market purchase or sale; the transaction was certified on 09/30/2025.
Richard W. Lavey, Executive Vice President and director of Hanover Insurance Group (THG), reported a non-derivative acquisition on 09/26/2025. The Form 4 shows 30.586 shares acquired at a price of $0 and reports 39,142.294 shares beneficially owned following the transaction. The filing explains these shares are restricted stock units (RSUs) issued under the company's 2022 Long-Term Incentive Plan as dividend equivalent rights tied to previously granted RSUs; these RSUs vest on the third anniversary of the original RSU grant date. The filing is signed via confirming statement by Lindsay L. Katz on 09/30/2025.
The reporting person, David John Lovely, Executive Vice President of The Hanover Insurance Group, Inc. (THG), received 11.375 shares of common stock on 09/26/2025 at no cost as a grant of restricted stock units (RSUs). These RSUs were issued under the company's 2022 Long-Term Incentive Plan as accruals for dividend equivalent rights tied to previously granted RSUs. After the grant, the reporting person beneficially owns 2,277.625 shares (reported as direct ownership). The granted RSUs vest on the third anniversary of the original underlying RSU grant date.
The filing shows that Willard T. Lee, Executive Vice President of Hanover Insurance Group (THG), was granted restricted stock units (RSUs) on 09/26/2025 under the company’s 2022 Long-Term Incentive Plan. The grant is described as dividend-equivalent RSUs tied to previously awarded RSUs; these new RSUs vest on the third anniversary of the original RSU grant date. The reported transaction lists 11.859 shares acquired at a price of $0, and the filing reports 5,479.704 shares beneficially owned following the transaction.
Hanover Insurance Group insider grant recorded on Form 4. The filing shows that Denise Lowsley, Executive Vice President, received a grant on 09/26/2025 under the company's 2022 Long-Term Incentive Plan. The entry reports 11.468 units granted (transaction code A) with a reported price of $0, and a post-transaction beneficial ownership figure of 5,130.496 shares. The explanatory note states these are restricted stock units issued to reflect accrued dividend equivalents on previously granted RSUs; they vest on the third anniversary of the original grant date.
Salvatore Bryan J, Executive Vice President and officer of Hanover Insurance Group, Inc. (THG), reported a transaction dated 09/26/2025 on SEC Form 4. The filing shows a grant of restricted stock units (RSUs) under the company’s 2022 Long-Term Incentive Plan in connection with accrued dividend equivalent rights tied to previously awarded RSUs. The new RSUs vest on the third anniversary of the original award date. The reported grant lists an acquisition entry and a zero cash price. The form was signed via confirming statement by Lindsay L. Katz on 09/30/2025.
Hanover Insurance Group (THG) officer Dennis Francis Kerrigan reported a non‑derivative acquisition on 09/26/2025 of 17.513 shares in the form of restricted stock units (RSUs) granted under the company's 2022 Long‑Term Incentive Plan at a $0 price. The filing shows Mr. Kerrigan is an Executive Vice President and the transaction increases his total beneficial ownership to 10,065.273 shares, which includes 33.525 shares acquired the same day under a dividend reinvestment plan exempt from Rule 16a‑11.
The RSUs relate to dividend equivalent rights tied to RSUs previously granted and will vest on the third anniversary of the original grant date. The form was submitted via a confirming statement filed 09/30/2025.
The Hanover Insurance Group, Inc. entered into an underwriting agreement to sell $500 million aggregate principal amount of its 5.500% Notes due 2035. The offering was underwritten by Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC as representatives of the several underwriters. The Notes were registered on Form S-3 and issued under the companys Base Indenture dated April 8, 2016, as supplemented by a Third Supplemental Indenture dated August 21, 2025. U.S. Bank Trust Company National Association (successor in interest to U.S. Bank National Association) is the trustee. Exhibits include the Underwriting Agreement, the Indenture and Third Supplemental Indenture, the form of security certificate, legal opinion and consent from Ropes & Gray LLP, and a company press release.
The Hanover Insurance Group, Inc. filed an S-3ASR registration statement for securities, incorporating prior SEC filings and standard exhibits. The filing lists corporate governance documents including an Amended and Restated Certificate of Incorporation and Amended and Restated By-Laws incorporated by reference, forms for indenture, warrants, preferred stock certificates and depositary/rights agreements, and legal and auditor consents from Ropes & Gray LLP and PricewaterhouseCoopers LLP. The document references provisions that may limit stockholder actions—including supermajority vote thresholds and restrictions on written consents and special meetings—and notes tax treatment language for original issue discount (zero-coupon) debt securities to be detailed in prospectus supplements. The filing includes signature blocks dated August 18, 2025.